Florida Senate - 2013                          SENATOR AMENDMENT
       Bill No. CS for CS for SB 966
       
       
       
       
       
       
                                Barcode 343270                          
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                                       .                                
                                       .                                
                                       .                                
                  Floor: WD            .                                
             05/01/2013 09:10 AM       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       Senator Garcia moved the following:
       
    1         Senate Amendment (with title amendment)
    2  
    3         Between lines 3382 and 3383
    4  insert:
    5         Section 76. Section 465.1903, Florida Statutes, is created
    6  to read:
    7         465.1903 OPPAGA report.—The Office of Program Policy
    8  Analysis and Government Accountability is directed to conduct an
    9  analysis that examines outcomes improvement, pharmacy network
   10  adequacy, patient access, cost savings, and pricing transparency
   11  issues in the pharmaceutical marketplace and submit a report to
   12  the Legislature on the findings from the analysis on or before
   13  December 1, 2013. The report must contain an analysis that
   14  includes a survey of different approaches taken in other states
   15  to address the issues in this section, and recommendations on
   16  all of the following:
   17         (1) Cost drivers of prescription drug prices and
   18  prescription drug-pricing trends.
   19         (2) Relative prescription drug pricing, reimbursement
   20  policies, practices and outcomes of patients receiving their
   21  drugs from retail and independent community pharmacies, mail
   22  order pharmacies, specialty pharmacies, and dispensing
   23  practitioners.
   24         (3) Options for regulation and improvements in transparency
   25  of contracting, reimbursement, and auditing practices of
   26  pharmacy benefit managers.
   27         (4) Options for reducing prescription drug costs to
   28  patients, including, but not limited to, maximizing
   29  pharmaceutical care and prescription drug availability to
   30  patients.
   31         (5) The use of comprehensive medication management to
   32  improve clinical outcomes.
   33  
   34  ================= T I T L E  A M E N D M E N T ================
   35         And the title is amended as follows:
   36         Delete line 337
   37  and insert:
   38         and land development; creating s. 465.1903, F.S.;
   39         directing the Office of Program Policy Analysis and
   40         Government Accountability to conduct an analysis and
   41         submit a report to the Legislature by a specified
   42         date; providing requirements for the report; amending
   43         s. 499.003, F.S.;